HEXAMETHONIUM BROMIDE CAS 55-97-0

Khoom Piav Qhia:

Khoom Lub Npe: HEXAMETHONIUM BROMIDE CAS TSIS TAU: 55-97-0

Lub ntsiab lus:

Hexamethonium bromide, N, N, N, N', N', N' -Hexamethylhexamethylenediammoniumdibromide;

gangliostat;

Methobromine;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Dawb crystalline hmoov thiab agglomerates

Kev Ntsuas: ≥99.00%

Melting Point: -285 ℃ (dec.)

Kev Cia Cia: Desiccate ntawm RT

Cov Ntaub Ntawv Kev Nyab Xeeb:

RTECS: BQ8575000

Cov Lus Hais Txog Kev Nyab Xeeb: S22; S24/25

WGK Lub Tebchaws Yelemees: 2

Hexamethonium yog ib qho tsis-depolarising ganglionic blocker, nicotinic nACh (NN) receptor antagonist.Target: nAChRHexamethonium yog cov tsis ua rau cov ganglionic blocker, nicotinic nACh receptor antagonist uas ua hauv autonomic ganglia los ntawm kev khi feem ntau hauv lossis tsis yog acetylcholine khi qhov chaw nws tus kheej. Nws tsis muaj kev cuam tshuam dab tsi rau muscarinic acetylcholine receptors (mAChR) nyob ntawm lub cev lub cev ntawm cov kab mob parasympathetic tab sis ua raws li antagonist ntawm nicotinic acetylcholine receptors nyob hauv kev mob siab thiab parasympathetic ganglia (NN). Hexamethonium bromide yog nicotinic acetyl choline receptor antagonist. Induces apoptosis thiab inhibits stimulatory effect ntawm nicotine ntawm endothelial cell DNA synthesis thiab loj hlob. Hexamethonium bromide hydrate yog ib qho inhibitor ntawm AChR α3 [1-3].

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: hexamethonium bromide cas 55-97-0, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: Tetrabutylammonium Acetate CAS 10534-59-5
• Tom ntej: Triethylmethylammonium Chloride CAS 10052-47-8